Literature DB >> 11389275

Ethical issues with genetic testing in pediatrics.

.   

Abstract

Advances in genetic research promise great strides in the diagnosis and treatment of many childhood diseases. However, emerging genetic technology often enables testing and screening before the development of definitive treatment or preventive measures. In these circumstances, careful consideration must be given to testing and screening of children to ensure that use of this technology promotes the best interest of the child. This statement reviews considerations for the use of genetic technology for newborn screening, carrier testing, and testing for susceptibility to late-onset conditions. Recommendations are made promoting informed participation by parents for newborn screening and limited use of carrier testing and testing for late-onset conditions in the pediatric population. Additional research and education in this developing area of medicine are encouraged.

Entities:  

Keywords:  Genetics and Reproduction

Mesh:

Year:  2001        PMID: 11389275     DOI: 10.1542/peds.107.6.1451

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  80 in total

Review 1.  The genetics of otitis media.

Authors:  Joseph H Goodwin; J Christopher Post
Journal:  Curr Allergy Asthma Rep       Date:  2002-07       Impact factor: 4.806

2.  Improving communication between doctors and parents after newborn screening.

Authors:  Michael H Farrell; Stephanie A Christopher; Audrey Tluczek; Karen Kennedy-Parker; Alison La Pean; Kerry Eskra; Jenelle Collins; Gary Hoffman; Julie Panepinto; Philip M Farrell
Journal:  WMJ       Date:  2011-10

3.  Ethical considerations associated with clinical use of next-generation sequencing in children.

Authors:  John D Lantos; Michael Artman; Stephen F Kingsmore
Journal:  J Pediatr       Date:  2011-12       Impact factor: 4.406

Review 4.  Research issues in genetic testing of adolescents for obesity.

Authors:  Mary E Segal; Pamela Sankar; Danielle R Reed
Journal:  Nutr Rev       Date:  2004-08       Impact factor: 7.110

5.  Prenatal whole genome sequencing: just because we can, should we?

Authors:  Greer Donley; Sara Chandros Hull; Benjamin E Berkman
Journal:  Hastings Cent Rep       Date:  2012-06-20       Impact factor: 2.683

Review 6.  New approaches to genetic counseling and testing for Alzheimer's disease and frontotemporal degeneration.

Authors:  Jill S Goldman
Journal:  Curr Neurol Neurosci Rep       Date:  2012-10       Impact factor: 5.081

Review 7.  Potential Uses and Inherent Challenges of Using Genome-Scale Sequencing to Augment Current Newborn Screening.

Authors:  Jonathan S Berg; Cynthia M Powell
Journal:  Cold Spring Harb Perspect Med       Date:  2015-10-05       Impact factor: 6.915

8.  Perceived Benefits, Risks, and Utility of Newborn Genomic Sequencing in the BabySeq Project.

Authors:  Stacey Pereira; Jill Oliver Robinson; Amanda M Gutierrez; Devan K Petersen; Rebecca L Hsu; Caroline H Lee; Talia S Schwartz; Ingrid A Holm; Alan H Beggs; Robert C Green; Amy L McGuire
Journal:  Pediatrics       Date:  2019-01       Impact factor: 7.124

Review 9.  Ethical issues in neonatal and pediatric clinical trials.

Authors:  Naomi Laventhal; Beth A Tarini; John Lantos
Journal:  Pediatr Clin North Am       Date:  2012-08-26       Impact factor: 3.278

Review 10.  Genetic risk assessments in individuals at high risk for inherited breast cancer in the breast oncology care setting.

Authors:  Tuya Pal; Susan T Vadaparampil
Journal:  Cancer Control       Date:  2012-10       Impact factor: 3.302

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.